Načítá se...
Does the Mixed Opioid Receptor Antagonist Naltrexone Mitigate Stimulant-Induced Euphoria?: A Double-Blind, Placebo Controlled Trial of Naltrexone
OBJECTIVE: Supra therapeutic doses of methylphenidate (MPH) activate mu opioid receptors, which are linked to euphoria. This study assessed whether naltrexone, a mixed mu opioid antagonist, may attenuate the euphoric effects of stimulants, thereby minimizing their abuse potential in subjects with At...
Uloženo v:
| Vydáno v: | J Clin Psychiatry |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6548180/ https://ncbi.nlm.nih.gov/pubmed/29617066 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4088/JCP.17m11609 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|